Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 1-Year High – Should You Buy?

by · The Cerbat Gem

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) reached a new 52-week high during mid-day trading on Friday . The company traded as high as $368.45 and last traded at $368.45, with a volume of 11 shares changing hands. The stock had previously closed at $334.85.

Bio-Rad Laboratories Stock Up 10.0 %

The firm has a market cap of $10.27 billion, a PE ratio of -12.25 and a beta of 0.73. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The firm has a 50 day moving average price of $332.14 and a 200-day moving average price of $306.31.

About Bio-Rad Laboratories

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

See Also